Called Dexter and created by DistalMotion, the innovation will allow surgeons to swap from robotic to keyhole surgery and back as required within the sterile field.
Dexter is expected to receive EU regulator sign-off in the form of a CE Mark by mid-2019, giving time to train a dedicated team in preparation for its launch.
"The market for surgical robots in the UK is limited by the cost and by the range of applications for which existing competitors are appropriate,” said Adam Power, development director of Surgical Innovations.
“Dexter offers a much broader range of surgical opportunities and employs a novel funding model. As a consequence, we expect 'Dexter' by DistalMotion SA to address the issues limiting the growth of surgical robots in the UK and to be a more acceptable solution for NHS and Private Hospitals."